Hämäläinen K - Search Results

1

Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice.

Sallinen H, Anttila M, Gröhn O, Koponen J, Hämäläinen K, Kholova I, Kosma VM, Heinonen S, Alitalo K, Ylä-Herttuala S. Sallinen H, et al. Among authors: hamalainen k. Cancer Gene Ther. 2011 Feb;18(2):100-9. doi: 10.1038/cgt.2010.56. Epub 2010 Sep 24. Cancer Gene Ther. 2011. PMID: 20865022

2

Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer.

Suhonen KA, Anttila MA, Sillanpää SM, Hämäläinen KM, Saarikoski SV, Juhola M, Kosma VM. Suhonen KA, et al. Eur J Cancer. 2007 May;43(8):1300-7. doi: 10.1016/j.ejca.2007.03.007. Epub 2007 Apr 19. Eur J Cancer. 2007. PMID: 17448653

3

Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer.

Sillanpää S, Anttila M, Suhonen K, Hämäläinen K, Turpeenniemi-Hujanen T, Puistola U, Tammi M, Sironen R, Saarikoski S, Kosma VM. Sillanpää S, et al. Among authors: hamalainen k. Tumour Biol. 2007;28(5):280-9. doi: 10.1159/000110426. Epub 2007 Oct 26. Tumour Biol. 2007. PMID: 17962725

4

Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.

Sallinen H, Anttila M, Narvainen J, Koponen J, Hamalainen K, Kholova I, Heikura T, Toivanen P, Kosma VM, Heinonen S, Alitalo K, Yla-Herttuala S. Sallinen H, et al. Among authors: hamalainen k. Mol Ther. 2009 Feb;17(2):278-84. doi: 10.1038/mt.2008.258. Epub 2008 Dec 2. Mol Ther. 2009. PMID: 19050699 Free PMC article.

5

Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.

Nykopp TK, Rilla K, Sironen R, Tammi MI, Tammi RH, Hämäläinen K, Heikkinen AM, Komulainen M, Kosma VM, Anttila M. Nykopp TK, et al. Among authors: hamalainen k. BMC Cancer. 2009 May 12;9:143. doi: 10.1186/1471-2407-9-143. BMC Cancer. 2009. PMID: 19435493 Free PMC article.

6

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression.

Tuhkanen H, Soini Y, Kosma VM, Anttila M, Sironen R, Hämäläinen K, Kukkonen L, Virtanen I, Mannermaa A. Tuhkanen H, et al. Among authors: hamalainen k. BMC Cancer. 2009 Aug 20;9:289. doi: 10.1186/1471-2407-9-289. BMC Cancer. 2009. PMID: 19695091 Free PMC article.

7

Downregulated CD44 and hyaluronan expression in vulvar intraepithelial neoplasia and squamous cell carcinomas.

Hämäläinen K, Kosma VM, Eloranta ML, Tammi R, Tammi M, Leppänen M, Leppänen M, Heinonen S, Anttila M. Hämäläinen K, et al. Acta Obstet Gynecol Scand. 2010;89(1):108-19. doi: 10.3109/00016340903341990. Acta Obstet Gynecol Scand. 2010. PMID: 19900133 Free article.

8

Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.

Nykopp TK, Rilla K, Tammi MI, Tammi RH, Sironen R, Hämäläinen K, Kosma VM, Heinonen S, Anttila M. Nykopp TK, et al. Among authors: hamalainen k. BMC Cancer. 2010 Sep 27;10:512. doi: 10.1186/1471-2407-10-512. BMC Cancer. 2010. PMID: 20875124 Free PMC article.

9

Antiangiogenic gene therapy with soluble VEGF-receptors -1, -2 and -3 together with paclitaxel prolongs survival of mice with human ovarian carcinoma.

Sopo M, Anttila M, Sallinen H, Tuppurainen L, Laurema A, Laidinen S, Hamalainen K, Tuunanen P, Koponen JK, Kosma VM, Heinonen S, Alitalo K, Yla-Herttuala S. Sopo M, et al. Among authors: hamalainen k. Int J Cancer. 2012 Nov 15;131(10):2394-401. doi: 10.1002/ijc.27495. Epub 2012 Mar 27. Int J Cancer. 2012. PMID: 22336998

10

Preclinical safety, toxicology, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer.

Tuppurainen L, Sallinen H, Kokki E, Koponen J, Anttila M, Pulkkinen K, Heikura T, Toivanen P, Hämäläinen K, Kosma VM, Heinonen S, Alitalo K, Ylä-Herttuala S. Tuppurainen L, et al. Among authors: hamalainen k. Hum Gene Ther Clin Dev. 2013 Mar;24(1):29-37. doi: 10.1089/humc.2013.006. Epub 2013 Apr 3. Hum Gene Ther Clin Dev. 2013. PMID: 23692381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters